Anebulo Pharmaceuticals, Inc. (ANEB) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 3 Buy, 1 Hold.
The consensus price target is $6.00, representing an upside of 1100% from the current price $0.50.
ANEB Stock — 12-Month Price Forecast
$6.00
▲ +1,100.00% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for Anebulo Pharmaceuticals, Inc., the price target is $6.00.
The average price target represents a +1,100.00% change from the last price of $0.50.
ANEB Analyst Ratings
Buy
Based on 4 analysts giving stock ratings to Anebulo Pharmaceuticals, Inc. in the past 3 months
